AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations. [electronic resource]
Producer: 20200421Description: 127-134 p. digitalISSN:- 1873-5010
- Angiotensin II Type 2 Receptor Blockers -- pharmacology
- Animals
- Child
- Cystic Fibrosis -- complications
- DNA -- genetics
- DNA Mutational Analysis
- Disease Models, Animal
- Female
- Follow-Up Studies
- Forced Expiratory Flow Rates -- physiology
- Genotype
- Humans
- Imidazoles -- pharmacology
- Lung -- physiopathology
- Lung Diseases -- etiology
- Male
- Mice
- Mice, Knockout
- Mutation
- Pyridines -- pharmacology
- Receptor, Angiotensin, Type 2 -- drug effects
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.